AEON Biopharma, Inc. Quarterly Operating Lease, Liability in USD from Q3 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
AEON Biopharma, Inc. quarterly Operating Lease, Liability history and growth rate from Q3 2023 to Q3 2024.
  • AEON Biopharma, Inc. Operating Lease, Liability for the quarter ending September 30, 2024 was $1.33M, a 283% increase year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.33M +$984K +283% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $1.4M Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $205K Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $278K Dec 31, 2023 10-K/A 2024-05-14
Q3 2023 $348K Sep 30, 2023 10-Q/A 2024-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.